Trastuzumab deruxtecan
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd) . Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.
Product Specifications
CAS Number
1826843-81-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximately 45.42 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Antibody-Drug Conjugates (ADCs)
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7265703-01 48 Well
Sheep LAG1 Longevity Assurance Homolog 3 (LASS3) ELISA Kit
Sign In for Pricing
View Details 
MBS7265703-02 96 Well
Sheep LAG1 Longevity Assurance Homolog 3 (LASS3) ELISA Kit
Sign In for Pricing
View Details 
MBS7265703-03 5x 96 Well
Sheep LAG1 Longevity Assurance Homolog 3 (LASS3) ELISA Kit
Sign In for Pricing
View Details MBS7265703-04 10x 96 Well
Sheep LAG1 Longevity Assurance Homolog 3 (LASS3) ELISA Kit
Sign In for Pricing
View Details